| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Septerna, Inc. (SEPN) has 8 insiders with recent SEC Form 4 filings, including 15 buys and 5 sells. SEPN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 210.0K | $7.60M | - | |
| COO | 178.2K | $6.45M | - | |
| VP | 92.9K | $3.36M | - | |
| Other | 55.0K | $1.99M | - | |
| CFO | 37.5K | $1.36M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Shaikhly Samira | Chief People Officer | Sale+OE | 6,250 | $35.08 | $219,224.37 | -88.7% | - | - | |
| Apr 15, 2026 | Bhatt Elizabeth | President And COO | Sale+OE | 4,000 | $24.34 | $97,343.36 | -0.8% | - | - | |
| Nov 10, 2025 | Long Daniel D. | SVP, Drug Discovery | Sell | 3,501 | $18.06 | $63,223.16 | -3.6% | +46.9% | - | |
| Mar 7, 2025 | Ezekowitz Alan86 | Director | Buy | 13,319 | $6.93 | $92,270.04 | +12.8% | +63.6% | +347.9% | |
| Mar 6, 2025 | Ezekowitz Alan86 | Director | Buy | 86,681 | $5.95 | $515,934.11 | +82.5% | +56.8% | +352.8% | |
| Feb 27, 2025 | Finer Jeffrey85 | CEO And President | Buy | 17,000 | $5.70 | $96,960.60 | +0.7% | +67.6% | +401.2% | |
| Feb 27, 2025 | Labrucherie Gil M84 | Chief Financial Officer | Buy | 10,000 | $5.69 | $56,866.68 | +15.1% | +67.6% | +401.2% | |
| Feb 24, 2025 | Third Rock Ventures Vi, L.P.84 | 10% Owner | Buy | 18,861 | $6.00 | $113,147.14 | +0.4% | +68.4% | +439.3% | |
| Feb 21, 2025 | Third Rock Ventures Vi, L.P.84 | 10% Owner | Buy | 1,040,342 | $5.93 | $6,167,378.00 | +15.0% | +63.4% | +370.3% | |
| Feb 21, 2025 | Labrucherie Gil M84 | Chief Financial Officer | Buy | 30,000 | $5.74 | $172,296.90 | +84.5% | +63.4% | +370.3% |